Neuroactive steroids and their methods of use

This disclosure relates to Compound 1, 0 OH 3 N-N H H H H CN H 3C 3 OH H (Compound 1) pharmaceutically acceptable salts, or pharmaceutically acceptable compositions thereof, for the treatment of CNS related disorders, e.g., tremor, e.g., essential tremor; depression; and anxiety disorder, and …